UNSPSC 51183510: Metformin hydrochloride

This classification denotes an anti-diabetic agent with the molecular formula C4H11N5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 786Z46389E, chemically known as 1,1-dimethylbiguanide but more generally known as metformin hydrochloride, which bears US NIH Compound Identifier 4091. European Medicines Agency schedules Metformin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03200MIG.

Most nations, for tariff and trade purposes, schedule metformin hydrochloride under HS 29252900 and SITC 51482. As of Q4 2014, METFORMIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Metformin hydrochloride bears US NLM identifiers UMLS ID C0770893 and NCI Concept Code C29251. SMILES: CN(C)C(=N)NC(=N)N.CL.

UNSPSC 51183510 Metformin hydrochloride is a Commodity code covering the procurement of metformin hydrochloride, a first-line oral antidiabetic medication, by state and local health systems, correctional facilities, and public health agencies. State and local governments purchase metformin hydrochloride as a generic pharmaceutical ingredient for inclusion in their formularies, typically as part of bulk pharmaceutical purchasing programs or through group purchasing organizations that aggregate demand across multiple jurisdictions. Issuing bodies include state departments of health, state prison systems, county health departments, municipal health clinics, and regional health authorities that maintain formularies and manage chronic disease treatment for Medicaid populations and incarcerated persons.

The source provided contains no record of recent state and local contract opportunities solicited under this code. Without posted RFPs, RFQs, ITBs, or IFBs naming metformin hydrochloride procurement, no geographic concentration, issuing-body activity pattern, or representative recent solicitation can be identified from current market signals.